Flip a coin until you get tails. This attack does 30 damage for each heads.
This attack does 100 damage to 1 of your opponent's Pokémon that has any damage counters on it. (Don't apply Weakness and Resistance for Benched Pokémon.)
Rebel Clash entered circulation in 2020. Series classification for this set is Sword & Shield.
Set size is 209 cards, which categorizes Rebel Clash as large. As of 2026, the set is 6 years old and sits in a modern-era collecting window.
In the Rebel Clash checklist, Mandibuzz occupies position #120 as a Rare card.
Mandibuzz appears in Rebel Clash, released in 2020. Card flavor text reads: "Although it's a bit of a ruffian, this Pokémon will take lost Vullaby under its wing and care for them till they're ready to leave the nest." Its card type is Pokémon.
The rarity label is Rare. Printed HP is 120.
Energy typing is Darkness. This card evolves from Vullaby.
The printed attacks highlight "Bone Rush" and "Blindside". It has a weakness to Lightning and resistance to Fighting.
For Mandibuzz in Rebel Clash, the current reference price is $0.20. Compared with last week, pricing is 4.8% lower.
Current value trails the 30-day mean ($0.21) by 2.8%. In the past 90 days, observed prices ranged from $0.17 to $0.22 (25% spread), a moderate-volatility profile.
Rarity classification for this copy is Rare.
A wider Mandibuzz checklist helps contextualize this specific Mandibuzz print. The current sample spans 6 comparable cards from 5 sets.
Observed alternatives run from $0.06 to $5.27 (8683% spread). The current card sits -81% versus the sampled alternative average of $1.04.
Notable alternatives include Mandibuzz #58 (Fates Collide) at $0.28, Mandibuzz #173 (Fusion Strike) at $0.07, Mandibuzz #93 (Team Up) at $0.24, and Mandibuzz #64 (White Flare) at $0.06.
Collector-focused market read: The market retraced 4.8% this week, and current pricing sits 9% below its recent high watermark. Observed 90-day bounds of $0.17 and $0.22 create a 25% band, matching a moderate-volatility profile.
Current value remains close to its 30-day mean ($0.21). The clearest graded reference is PSA 9 at $15.00, or +7400% relative to raw.
